Northern Trust’s IGC Pharma IGC Stock Holding History

Northern Trust’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.8K	Hold	113,407	–	–	﹤0.01%	4305
2025 Q4	$31.9K	Hold	113,407	–	–	﹤0.01%	4343
2025 Q3	$47.3K	Hold	113,407	–	–	﹤0.01%	4291
2025 Q2	$34.7K	Hold	113,407	–	–	﹤0.01%	4289
2025 Q1	$32.3K	Hold	113,407	–	–	﹤0.01%	4290
2024 Q4	$38.1K	Buy	113,407 +42,380	+60%	+$15.9K	﹤0.01%	4298
2024 Q3	$30.3K	Hold	71,027	–	–	﹤0.01%	4283
2024 Q2	$30.8K	Sell	71,027 -337	-0.5%	-$168	﹤0.01%	4282
2024 Q1	$28.5K	Hold	71,364	–	–	﹤0.01%	4299
2023 Q4	$20K	Hold	71,364	–	–	﹤0.01%	4365
2023 Q3	$25.6K	Hold	71,364	–	–	﹤0.01%	4286
2023 Q2	$22.2K	Hold	71,364	–	–	﹤0.01%	4389
2023 Q1	$24.2K	Buy	71,364 +8,036	+13%	+$3.01K	﹤0.01%	4412
2022 Q4	$20.1K	Hold	63,328	–	–	﹤0.01%	4486
2022 Q3	$27K	Hold	63,328	–	–	﹤0.01%	4485
2022 Q2	$34K	Hold	63,328	–	–	﹤0.01%	4524
2022 Q1	$60K	Hold	63,328	–	–	﹤0.01%	4494
2021 Q4	$62K	Hold	63,328	–	–	﹤0.01%	4553
2021 Q3	$94K	Hold	63,328	–	–	﹤0.01%	4417
2021 Q2	$104K	Hold	63,328	–	–	﹤0.01%	4355
2021 Q1	$113K	Buy	63,328 +337	+0.5%	+$612	﹤0.01%	4258
2020 Q4	$98K	Sell	62,991 -21,542	-25%	-$31.8K	﹤0.01%	4117
2020 Q3	$88K	Sell	84,533 -5,523	-6%	-$5.61K	﹤0.01%	3990
2020 Q2	$54K	Sell	90,056 -3,541	-4%	-$1.92K	﹤0.01%	4047
2020 Q1	$46K	Hold	93,597	–	–	﹤0.01%	3967
2019 Q4	$59K	Hold	93,597	–	–	﹤0.01%	4027
2019 Q3	$91K	Buy	93,597 +52,318	+127%	+$63K	﹤0.01%	3938
2019 Q2	$68K	Buy	+41,279	New	+$58.3K	﹤0.01%	4030

Other funds holding IGC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $148M AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Northern Trust's IGC Position: Q1 2026 in Review

Northern Trust held its IGC Pharma (IGC) position steady in Q1 2026 at 113,407 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4305.

Northern Trust first reported a position in IGC in Q2 2019 and has held it in 28 quarters since. The position peaked at $113K in Q1 2021. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

Northern Trust held 113,407 shares of IGC Pharma worth $29.8K as of Q1 2026.
Northern Trust left its IGC Pharma share count unchanged in Q1 2026.
IGC Pharma made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4305 holding.
Northern Trust first reported a position in IGC Pharma in Q2 2019 and has held it in 28 quarters since.
Northern Trust's IGC Pharma position peaked at $113K in Q1 2021.
35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.